A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.

1. Rosell, R.
2. Felip, E.
3. Massuti, B.
4. González-Larriba, J.L.
5. Benito, D.
6. López-Cabrerizo, M.P.
7. Salamanca, O.
8. Camps, C.
9. Puerto-Pica, J.